Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01039987 · ClinicalTrials.gov registry record

Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease

A clinical trial of Autosomal Dominant Polycystic Kidney Disease, sponsored by University of Pittsburgh.

Completed
Registry status
211
Enrollment target
5
Study locations

NCT01039987: Completed study of Autosomal Dominant Polycystic Kidney Disease, sponsored by University of Pittsburgh.

NCT01039987 is a study of Autosomal Dominant Polycystic Kidney Disease that has completed, run by University of Pittsburgh. The registered enrollment target is 211 participants, above the 138-participant average among 9 other Autosomal Dominant Polycystic Kidney Disease trials with a reported enrollment target (53% higher). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01039987, a study of Autosomal Dominant Polycystic Kidney Disease, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
211 participants
Enrollment target
5
Study locations

Study Summary

The Division of Kidney Urology and Hematology Disease (DKUHD) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) funded a cooperative agreement (UO1) for a consortium of participating clinical centers (PCCs) and a data coordinating and imaging analysis center (DCIAC) to develop and implement studies to test whether imaging techniques can provide accurate and reproducible markers of progression of renal disease in patients with polycystic kidney disease. The awarded participating clinical centers are Emory University, University of Kansas, and Mayo Foundation (with a subcontract to the University of Alabama). The awarded DCIAC is Washington University in St. Louis. Due to the relocation of the DCIAC P.I. from Washington University to the University of Pittsburgh, the DCIAC for CRISP II is located at the University of Pittsburgh.

Conditions Studied

Autosomal Dominant Polycystic Kidney Disease

Study Locations (5)

Alabama

  • University of Alabama-Birmingham - Birmingham

Georgia

  • Emory University - Atlanta

Kansas

  • University of Kansas - Kansas City

Minnesota

  • Mayo Clinic - Rochester

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 211 participants
Start Date 1999-09
Est. Completion 2011-03
University of Pittsburgh

1,238 total trials

What the finished NCT01039987 record still lists

NCT01039987 is an observational study that tracks outcomes without assigning an intervention. The registered 211 participants enrollment target is mid-sized for trials with a published cap, above the 138-participant average among 9 other Autosomal Dominant Polycystic Kidney Disease trials with a reported enrollment target (53% higher).

The record links to 1 condition, with Autosomal Dominant Polycystic Kidney Disease appearing as the primary indexed condition, and to 0 interventions.

NCT01039987 lists 5 locations in 5 states (Alabama, Georgia, Kansas).

Frequently Asked Questions

What is clinical trial NCT01039987 about?

NCT01039987 is a clinical study titled "Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease". The Division of Kidney Urology and Hematology Disease (DKUHD) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) funded a cooperative agreement (UO1) for a consortium of participating clinical centers (PCCs) and a data coordinating and imaging analysis center (DCIAC) to ...

What is the current status of trial NCT01039987?

This trial is currently completed. The enrollment target is 211 participants. The study started on 1999-09. Estimated completion is 2011-03.

What conditions does trial NCT01039987 study?

This clinical trial studies the following conditions: Autosomal Dominant Polycystic Kidney Disease.

Who is sponsoring clinical trial NCT01039987?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01039987 being conducted?

This trial has 5 study locations across Alabama, Georgia, Kansas, Minnesota, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Autosomal Dominant Polycystic Kidney Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01039987's enrollment target sits among peer trials

211 3rd of 9 higher than 7 of 9 other Autosomal Dominant Polycystic Kidney Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autosomal Dominant Polycystic Kidney Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06698796 · 211 participants · Phase 3

    A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

  • NCT04228978 · 212 participants · NA

    Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

  • NCT04725721 · 212 participants · NA

    Testing FIRST in Youth Outpatient Psychotherapy

  • NCT06257576 · 212 participants · Phase 3

    Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT01039987, the US trial registry maintained by the National Library of Medicine. NCT01039987 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.